# Single Ascending Dose Study of MSD-001 in Healthy Participants

> **NCT06702332** · PHASE1 · COMPLETED · sponsor: **Mindstate Design Labs** · enrollment: 47 (actual)

## Conditions studied

- Mental Health Disorders

## Interventions

- **DRUG:** MSD-001
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT06702332
- **Lead sponsor:** Mindstate Design Labs
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-11
- **Primary completion:** 2025-06-19
- **Final completion:** 2025-07-11
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06702332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06702332, "Single Ascending Dose Study of MSD-001 in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06702332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*